Establishment Labs Holdings Inc. (ESTA) |
38.94 -1.18 (-2.94%) 10-10 16:00 |
Open: | 40.04 |
High: | 40.515 |
Low: | 38.38 |
Volume: | 234,487 |
Market Cap: | 1,128(M) |
PE Ratio: | -12.64 |
Exchange: | NASDAQ Capital Market |
Industry: | Medical - Devices |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 43.02 |
Resistance 1: | 40.54 |
Pivot price: | 40.66 |
Support 1: | 36.53 |
Support 2: | 30.39 |
52w High: | 50.85 |
52w Low: | 26.56 |
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
EPS | -3.080 |
Book Value | 0.790 |
PEG Ratio | 0.00 |
Gross Profit | 4.118 |
Profit Margin (%) | -49.89 |
Operating Margin (%) | -27.50 |
Return on Assets (ttm) | -12.8 |
Return on Equity (ttm) | -261.2 |
Thu, 09 Oct 2025
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report - Business Wire
Mon, 06 Oct 2025
Does Establishment Labs’ (ESTA) Increased Liquidity Access Signal a Shift in Risk Management Strategy? - simplywall.st
Sat, 04 Oct 2025
Establishment Labs Holdings (ESTA): Evaluating Valuation After Enhanced Credit Agreement and New $25 Million Term Loan - simplywall.st
Fri, 03 Oct 2025
Establishment Labs Amends Credit Agreement with Oaktree - TipRanks
Wed, 17 Sep 2025
Establishment Labs appoints Peter Caldini as CEO - MSN
Thu, 21 Aug 2025
Earnings call transcript: Establishment Labs Q2 2025 sees revenue growth but EPS miss - Investing.com
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |